Microcurrent Therapy
Mechanism of Microcurrent Therapy Activating Brainstem Nerve Cells
The exact mechanism by which Microcurrent produces effects is not fully known. However, based on previous and ongoing studies, it appears that the Microcurrent waveform activates particular groups of nerve cells that are located at the brainstem. These groups of nerve cells produce the chemicals serotonin and acetylcholine which can affect the chemical activity of nerve cells that are both nearby and at more distant sites in the nervous system. In fact, these cells are situated to control the activity of nerve pathways that run up into the brain and that course down into the spinal cord. By changing the electrical and chemical activity of certain nerve cells in the brainstem, Microcurrent appears to amplify activity in some neurological systems, and diminish activity in others. This neurological ‘fine tuning’ is called modulation, and occurs either as a result of, or together with the production of a certain type of electrical activity pattern in the brain known as an alpha state which can be measured on electroencephalogram (EEG) recordings. Such alpha rhythms are accompanied by feelings of calmness, relaxation, and increased mental focus. The neurological mechanisms that are occurring during the alpha state appear to decrease stress-effects, reduce agitation, stabilize mood, and regulate both sensations and perceptions of particular types of pain.
These effects can be produced after a single treatment, and repeated treatments have been shown to increase the relative strength and duration of these effects. In some cases, effects have been stable and permanent, suggesting that the electrical and chemical changes evoked by Microcurrent have led to a durable re-tuning back to normal function.
How Microcurrent Work
- Amplifies some neurological system activity and deactivates others in a fine-tuning process called neuromodulation
- Neuromodulation either results from, or occurs with, alpha states in the brain that are measurable on an EEG
TREATING PAIN
Microcurrent Electrical Therapy (MET) delivers low-level electrical current that has been proven to effectively reduce acute, chronic, and post-traumatic pain. MET has an extensive safety record, with few side effects (less than 1%) and considerable scientific evidence of the significant results patients may achieve.
When you’re suffering from pain, you want to know only one thing: when will it end? Pain can come from many sources and in varying degrees, but no matter the source or severity, you need quick and long-lasting relief to get you back to the activities you enjoy.
Alpha-Stim® can give you long-lasting relief, quickly and safely.
PROVEN TO REDUCE PAIN
- Microcurrent can be used as a first-line therapy, or as an adjunct to pharmacotherapy without polypharmacy effects
- Microcurrent technology is safe, with no serious adverse events reported in over 30 years of clinical use
- Microcurrent treatments are cumulative; however, most patients show at least some improvement after the first treatment
The Fundamentals: An Electrical Intervention
- The brain and nervous system function electrochemically and can be readily modulated by electrical intervention1,2
- Microcurrent impacts electrochemical function at the cellular level to reduce pain related to a variety of causes
Non-addictive Option For At-risk Patients
Microcurrent technology is a non-addictive therapy that is a treatment solution for patients who:
- Are addicted to, or at risk of, addiction to opiates
- Have drug interaction risk factors
- Have vocational restrictions on narcotic use
- Are elderly
- At risk due to compromised organ systems
- Are medication resistant
TREATING MOOD CONDITIONS
Treating Anxiety, Depression, and Insomnia with the Microcurrent therapy
Cranial Electrotherapy Stimulation (CES) uses low-level electrical current to safely and effectively treat anxiety, depression, and insomnia. Initially cleared by the FDA in 1992 as a prescriptive, noninvasive treatment, CES has an extensive safety record, with few side effects (less than 1%) and considerable scientific evidence of the significant results patients can achieve.
Microcurrent treatments are cumulative; however, most patients show at least some improvement after the first treatment
Microcurrent technology is safe, with no serious adverse events reported in over 30 years of clinical use
Microcurrent devices can be used as a first-line therapy, or as an adjunct to pharmacotherapy (without polypharmacy effects)
CLINICAL STUDIES PROVE FOR ANXIETY
IMMEDIATE RESULTS
Using Alpha-Stim during procedures, dental patients
reported an average of 61% less anxiety.2
LONG-TERM EFFECTIVENESS
After 5 weeks of treatment with Alpha-Stim, participants
reported an average of 94% decrease in anxiety.
CLINICAL STUDIES PROVE FOR DEPRESSION
DEPRESSION SYMPTOMS REDUCTION IN PEOPLE WITH ANXIETY AND DEPRESSION
82% of participants reported a decrease of ≥ 50% or greater in depression scores.
LONG-TERM EFFECTIVENESS
After 6 weeks of treatment, Alpha-Stim use
CLINICAL STUDIES FOR REDUCING INSOMNIA
MORE SLEEP
After only 5 treatments with Alpha-Stim, military service members with insomnia reported an increase of 43 minutes of sleep.
BETTER SLEEP
The number of subjects rating their quality of sleep as poor dropped from 60% at the beginning of the study to 5%.
The Impact: An Electrical Intervention
- The brain functions electrochemically and can be readily modulated by electrical intervention
- Microcurrent impacts the electrochemical functions of the brain to improve patients’ emotional and physiologic states
- Designed to effect the activity of subcortical brain structures known to regulate emotions
- fMRI studies demonstrate the waveform current changes the appropriate brain structures
The Results: Significant Improvement, Quickly, With Lasting Effect
Electroencephalographic studies show:
- Increased alpha activity
- Decreased delta activity
- Decreased beta activity
QEEG changes in 30 subjects treated with 20 minutes of Alpha Stim CES. There is an increase (Red) in alpha activity with a simultaneous decrease (Blue) in beta and delta2.